Salsolinol improves angiotensin II‑induced myocardial fibrosis in vitro via inhibition of LSD1 through regulation of the STAT3/Notch‑1 signaling pathway

por Zhang, Xian, Shao, Ze, Ni, Yuchao, Chen, Feilong, Yu, Xia, Wen, Jiasheng
Publicado 2023

Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bay...

por Chen, Junru, Ni, Yuchao, Sun, Guangxi, Liao, Banghua, Zhang, Xingming, Zhao, Jinge, Zhu, Sha, Wang, Zhipeng, Shen, Pengfei, Zeng, Hao
Publicado 2020

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis

por Wang, Zhipeng, Ni, Yuchao, Chen, Junru, Sun, Guangxi, Zhang, Xingming, Zhao, Jinge, Zhu, Xudong, Zhang, Haoran, Zhu, Sha, Dai, Jindong, Shen, Pengfei, Zeng, Hao
Publicado 2020

Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Popula...

por Chen, Junru, Ni, Yuchao, Sun, Guangxi, Zhu, Sha, Zhao, Jinge, Wang, Zhipeng, Zhang, Haoran, Zhu, Xudong, Zhang, Xingming, Dai, Jindong, Shen, Pengfei, Zeng, Hao
Publicado 2020

Mutations in epigenetic regulator KMT2C detected by liquid biopsy are associated with worse survival in prostate cancer patients

por ZHU, SHA, XU, NANWEI, LIANG, JIAYU, ZHAO, FENGNIAN, WANG, ZILIN, NI, YUCHAO, DAI, JINDONG, ZHAO, JINGE, ZHANG, XINGMING, CHEN, JUNRU, SUN, GUANGXI, SHEN, PENGFEI, ZENG, HAO
Publicado 2023

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors

por Zhang, Haoran, Zhang, Xingming, Zhu, Xudong, Ni, Yuchao, Dai, Jindong, Zhu, Sha, Sun, Guangxi, Wang, Zhipeng, Chen, Junru, Zhao, Jinge, Zeng, Hao, Li, Zi, Shen, Pengfei
Publicado 2020

Corticosteroid switch from prednisone to dexamethasone in metastatic castration-resistant prostate cancer patients with biochemical progression on abiraterone acetate plus predniso...

por Yang, Zhenyu, Ni, Yuchao, Zhao, Diwei, Zhang, Yijun, Wang, Jun, Jiang, Lijuan, Chen, Dong, Wu, Zhiming, Wang, Yanjun, He, Liru, Shi, Yanxia, Zhou, Fangjian, Zeng, Hao, Li, Yonghong
Publicado 2021

Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma

por Zhu, Xudong, Zhang, Xingming, Sun, Guangxi, Liu, Zhenhua, Zhang, Haoran, Yang, Yaojing, Ni, Yuchao, Dai, Jindong, Zhu, Sha, Chen, Junru, Zhao, Jinge, Wang, Zhipeng, Zeng, Hao, Shen, Pengfei
Publicado 2021

Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone

por Zhu, Sha, Ni, Yuchao, Sun, Guangxi, Wang, Zilin, Chen, Junru, Zhang, Xingming, Zhao, Jinge, Zhu, Xudong, Dai, Jindong, Liu, Zhenhua, Liang, Jiayu, Zhang, Haoran, Zhang, Yaowen, Shen, Pengfei, Zeng, Hao
Publicado 2021

Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis

por Chen, Junru, Zhang, Yaowen, Zhang, Xingming, Zhao, Jinge, Ni, Yuchao, Zhu, Sha, He, Ben, Dai, Jindong, Wang, Zhipeng, Wang, Zilin, Liang, Jiayu, Zhu, Xudong, Shen, Pengfei, Zeng, Hao, Sun, Guangxi
Publicado 2022

The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer

por Wang, Zhipeng, Liu, Haoyang, Zhao, Jinge, Chen, Junru, Zhu, Sha, Dai, Jindong, Ni, Yuchao, Xu, Nanwei, Zhao, Fengnian, He, Ben, Zhang, Xingming, Liang, Jiayu, Sun, Guangxi, Liu, Zhenhua, Shen, Pengfei, Zeng, Hao
Publicado 2023

Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer

por Wang, Zhipeng, Liu, Haoyang, Zhao, Jinge, Chen, Junru, Zhu, Sha, Dai, Jindong, Ni, Yuchao, Xu, Nanwei, Zhao, Fengnian, He, Ben, Zhang, Xingming, Liang, Jiayu, Sun, Guangxi, Liu, Zhenhua, Shen, Pengfei, Zeng, Hao
Publicado 2023

Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report

por Zhu, Sha, Bao, Yige, Zheng, Linmao, Zhao, Jinge, Chen, Yuntian, Huang, Rui, Sun, Guangxi, Zhao, Fengnian, Zhang, Xingming, Liang, Jiayu, Chen, Junru, Wang, Zhipeng, Ni, Yuchao, Chen, Ni, Shen, Pengfei, Zeng, Hao
Publicado 2022

Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer

por Zhu, Sha, Ni, Yuchao, Wang, Zilin, Zhang, Xingming, Zhang, Yaowen, Zhao, Fengnian, Dai, Jindong, Wang, Zhipeng, Zhu, Xudong, Chen, Junru, Zhao, Jinge, Zeng, Yuhao, Chen, Ni, Zeng, Peng, Shen, Pengfei, Sun, Guangxi, Zeng, Hao
Publicado 2022

Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma

por Zhao, Junjie, Liang, Jiayu, Yang, Yang, Sun, Guangxi, Zhang, Xingming, Zhao, Jinge, Hu, Xu, Chen, Junru, Zhu, Sha, Ni, Yuchao, Zhang, Yaowen, Dai, Jindong, Wang, Zhipeng, Wang, Zilin, Zeng, Yuhao, Yao, Jin, Chen, Ni, Shen, Pengfei, Liu, Zhenhua, Zeng, Hao
Publicado 2022

Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration‐resistant prostate cancer patients

por Zhu, Sha, Chen, Junru, Ni, Yuchao, Zhang, Haoran, Liu, Zhenhua, Shen, Pengfei, Sun, Guangxi, Liang, Jiayu, Zhang, Xingming, Wang, Zhipeng, Wei, Qiang, Li, Xiang, Chen, Ni, Li, Zhiping, Wang, Xin, Shen, Yali, Yao, Jin, Huang, Rui, Liu, Jiyan, Cai, Diming, Zeng, Hao
Publicado 2021

The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first‐line therapy for patients with metastatic castration‐resistant pr...

por Wang, Zhipeng, Zhu, Sha, Zhao, Jinge, Nie, Ling, Chen, Xueqin, Zhang, Mengni, Chen, Ni, Sun, Guangxi, Chen, Junru, Ni, Yuchao, Dai, Jindong, Liu, Zhenhua, Tao, Ronggui, Zhang, Xingming, Zhu, Xudong, Zhang, Haoran, Liang, Jiayu, Wang, Zilin, He, Ben, Shen, Pengfei, Zeng, Hao
Publicado 2021

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)

por Zhu, Sha, Zhao, Jinge, Nie, Ling, Yin, Wenlian, Zhang, Yaowen, Zhao, Fengnian, Ni, Yuchao, Zhang, Xingming, Wang, Zhipeng, Dai, Jindong, Liu, Zhenhua, Chen, Junru, Zeng, Yuhao, Wang, Zilin, Sun, Guangxi, Liang, Jiayu, Zhao, Xiaochen, Zhu, Xudong, Tao, Ronggui, Yang, Jiyu, He, Ben, Chen, Ni, Shen, Pengfei, Zeng, Hao
Publicado 2022

Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients

por Zeng, Yuhao, Zhu, Sha, Wang, Zilin, Chen, Junru, Dai, Jindong, Liu, Zhenhua, Sun, Guangxi, Liang, Jiayu, Zhang, Xingming, Wang, Zhipeng, Zhao, Jinge, Ni, Yuchao, Yang, Jiyu, Wang, Minghao, Wei, Qiang, Li, Xiang, Chen, Ni, Li, Zhiping, Wang, Xin, Shen, Yali, Yao, Jin, Huang, Rui, Liu, Jiyan, Cai, Diming, Zeng, Hao, Shen, Pengfei
Publicado 2023

Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma

por Sun, Guangxi, Chen, Junru, Liang, Jiayu, Yin, Xiaoxue, Zhang, Mengni, Yao, Jin, He, Ning, Armstrong, Cameron M., Zheng, Linmao, Zhang, Xingming, Zhu, Sha, Sun, Xiaomeng, Yang, Xiaoxia, Zhao, Wanbin, Liao, Banghua, Pan, Xiuyi, Nie, Ling, Yang, Ling, Chen, Yuntian, Zhao, Jinge, Zhang, Haoran, Dai, Jindong, Shen, Yali, Liu, Jiyan, Huang, Rui, Liu, Jiandong, Wang, Zhipeng, Ni, Yuchao, Wei, Qiang, Li, Xiang, Zhou, Qiao, Huang, Haojie, Liu, Zhenhua, Shen, Pengfei, Chen, Ni, Zeng, Hao
Publicado 2021